IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers
Authors:
Top Cited Papers
Open Access
- 3 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 921864
Abstract
Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common systemic vasculitis in children, characterized by diverse clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to systemic involvement. The incidence of IgAV is geographically and ethnically variable, with a prevalence in autumn and winter, suggesting a driving role that genetic and environmental factors play in the disease. Although IgAV has a certain degree of natural remission, it varies widely among individuals. Some patients can suffer from severe renal involvement and even progress to end-stage renal disease. Its pathogenesis is complex and has not been fully elucidated. The formation of galactose-deficient IgA1 (Gd-IgA1) and related immune complexes plays a vital role in promoting the occurrence and development of IgAV nephritis. In addition, neutrophil activation is stimulated through the binding of IgA to the Fc alpha receptor I expressed on its surface, resulting in systemic vascular inflammation and tissue damage. Starting from the epidemiological characteristics, this article will review the role of immunological factors such as Gd-IgA1, autoantibodies, circulating immune complexes, complement system, cellular immunization, and the contributions of environmental and genetic factors in the pathogenesis of IgAV, and conclude with the major biomarkers for IgAV.Keywords
This publication has 182 references indexed in Scilit:
- High glucose modulates IL‐6 mediated immune homeostasis through impeding neutrophil extracellular trap formationFEBS Letters, 2013
- Transglutaminase is essential for IgA nephropathy development acting through IgA receptorsJournal of Experimental Medicine, 2012
- Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schönlein purpura nephritisKidney International, 2011
- Innate control of B cell responsesTrends in Immunology, 2011
- Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityJournal of Clinical Investigation, 2009
- Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathwayClinical and Experimental Immunology, 2006
- RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002
- Translating the Histone CodeScience, 2001
- Schönlein-Henoch purpura associated with gastric Helicobacter pylori infectionJournal of the American Academy of Dermatology, 1995